Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Moxifloxacin Hydrochloride Injection

Approval Number

国药准字H20193431

Company北大医药股份有限公司

Registration Date

August 23, 2024

Drug Information

Generic Name

盐酸莫西沙星注射液

Dosage Form

注射剂

Strength

20ml：0.4g（按C₂₁H₂₄FN₃O₄计）

Drug Type

化学药品

Registration Date

August 23, 2024

Company Information

Applicant Company

Company Name北大医药股份有限公司

Company Address

重庆市北碚区水土镇方正大道21号

Manufacturing Company

Company Name北大医药股份有限公司

Company Address

重庆市北碚区水土镇方正大道21号附1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy